Cita APA (7a ed.)
Lalu, A. C., Kundil, V. T., Ben, J. B., R, D. R., Amritha, T., Suhail, S., . . . Abhithaj, J. (2025). Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach. Viruses. https://doi.org/10.3390/v17121613
Cita Chicago Style (17a ed.)
Lalu, Anjana C., Varun Thachan Kundil, Joseph Bristow Ben, Dev Radul R, Thaikkad Amritha, Subair Suhail, Raju Rajesh, y Jayanandan Abhithaj. "Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach." Viruses 2025. https://doi.org/10.3390/v17121613.
Cita MLA (9a ed.)
Lalu, Anjana C., et al. "Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach." Viruses, 2025, https://doi.org/10.3390/v17121613.
Precaución: Estas citas no son 100% exactas.